• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经影像学研究注意缺陷多动障碍中物质使用障碍风险增加的神经关联——一项系统综述

Neuroimaging the neural correlates of increased risk for substance use disorders in attention-deficit/hyperactivity disorder-A systematic review.

作者信息

Adisetiyo Vitria, Gray Kevin M

机构信息

Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, South Carolina.

Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina.

出版信息

Am J Addict. 2017 Mar;26(2):99-111. doi: 10.1111/ajad.12500. Epub 2017 Jan 20.

DOI:10.1111/ajad.12500
PMID:28106934
Abstract

BACKGROUND/OBJECTIVES: Children with attention-deficit/hyperactivity disorder (ADHD) are nearly three times more likely to develop substance use disorders (SUD) than their typically developing peers. Our objective was to review the existing neuroimaging research on high-risk ADHD (ie, ADHD with disruptive behavior disorders, familial SUD and/or early substance use), focusing on impulsivity as one possible mechanism underlying SUD risk.

METHODS

A PubMed literature search was conducted using combinations of the keywords "ADHD," "substance use," "substance use disorder," "SUD," "addiction," "dependence," "abuse," "risk," "brain" "MRI," "imaging" and "neuroimaging." Studies had to include cohorts that met diagnostic criteria for ADHD; studies of individuals with ADHD who all met criteria for SUD were excluded. Eight studies met the search criteria.

RESULTS

Individuals with high-risk ADHD have hyperactivation in the motivation-reward processing brain network during tasks of impulsive choice, emotion processing, and risky decision-making. During response inhibition tasks, they have hypoactivation in the inhibitory control brain network. However, studies focusing on this latter circuit found hypoactivation during inhibitory control tasks, decreased white matter microstructure coherence and reduced cortical thickness in ADHD independent of substance use history.

DISCUSSION/CONCLUSIONS: An exaggerated imbalance between the inhibitory control network and the motivation-reward processing network is theorized to distinguish individuals with high-risk ADHD. Preliminary findings suggest that an exaggerated aberrant reward processing network may be the driving neural correlate of increased SUD risk in ADHD.

SCIENTIFIC SIGNIFICANCE

Neural biomarkers of increased SUD risk in ADHD could help clinicians identify which patients may benefit most from SUD prevention. Thus, more neuroimaging research on this vulnerable population is needed. (Am J Addict 2017;26:99-111).

摘要

背景/目的:患有注意力缺陷多动障碍(ADHD)的儿童发展为物质使用障碍(SUD)的可能性几乎是其发育正常的同龄人三倍。我们的目的是回顾现有的关于高危ADHD(即伴有破坏性行为障碍、家族性SUD和/或早期物质使用的ADHD)的神经影像学研究,重点关注冲动性这一可能构成SUD风险的潜在机制。

方法

使用关键词“ADHD”、“物质使用”、“物质使用障碍”、“SUD”、“成瘾”、“依赖”、“滥用”、“风险”、“大脑”、“MRI”、“成像”和“神经影像学”的组合在PubMed上进行文献检索。研究必须纳入符合ADHD诊断标准的队列;排除所有符合SUD标准的ADHD个体的研究。八项研究符合检索标准。

结果

高危ADHD个体在冲动选择、情绪处理和风险决策任务期间,其动机-奖赏处理脑网络呈现过度激活。在反应抑制任务期间,他们的抑制控制脑网络呈现激活不足。然而,关注后一回路的研究发现,在抑制控制任务期间,ADHD患者激活不足,白质微结构连贯性降低,皮质厚度减少,且与物质使用史无关。

讨论/结论:理论上认为,抑制控制网络与动机-奖赏处理网络之间的过度失衡可区分高危ADHD个体。初步研究结果表明,过度异常的奖赏处理网络可能是ADHD患者SUD风险增加的驱动神经关联因素。

科学意义

ADHD患者SUD风险增加的神经生物标志物有助于临床医生识别哪些患者可能从SUD预防中获益最大。因此,需要对这一脆弱人群进行更多的神经影像学研究。(《美国成瘾杂志》2017年;26:99 - 111)

相似文献

1
Neuroimaging the neural correlates of increased risk for substance use disorders in attention-deficit/hyperactivity disorder-A systematic review.神经影像学研究注意缺陷多动障碍中物质使用障碍风险增加的神经关联——一项系统综述
Am J Addict. 2017 Mar;26(2):99-111. doi: 10.1111/ajad.12500. Epub 2017 Jan 20.
2
Atypical antipsychotics for disruptive behaviour disorders in children and youths.用于治疗儿童和青少年破坏性行为障碍的非典型抗精神病药物。
Cochrane Database Syst Rev. 2017 Aug 9;8(8):CD008559. doi: 10.1002/14651858.CD008559.pub3.
3
Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.患有共病抽动障碍的儿童注意力缺陷多动障碍(ADHD)的药物治疗。
Cochrane Database Syst Rev. 2018 Jun 26;6(6):CD007990. doi: 10.1002/14651858.CD007990.pub3.
4
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
5
Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.安非他酮用于治疗成人注意力缺陷多动障碍(ADHD)。
Cochrane Database Syst Rev. 2017 Oct 2;10(10):CD009504. doi: 10.1002/14651858.CD009504.pub2.
6
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.用于治疗儿童和青少年注意力缺陷多动障碍(ADHD)的哌甲酯——非随机研究中不良事件的评估
Cochrane Database Syst Rev. 2018 May 9;5(5):CD012069. doi: 10.1002/14651858.CD012069.pub2.
7
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
8
Stimulant and non-stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy.兴奋剂和非兴奋剂药物治疗注意缺陷多动障碍和癫痫患者。
Cochrane Database Syst Rev. 2022 Jul 13;7(7):CD013136. doi: 10.1002/14651858.CD013136.pub2.
9
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
10
Methylphenidate for children and adolescents with autism spectrum disorder.用于治疗自闭症谱系障碍儿童和青少年的哌醋甲酯
Cochrane Database Syst Rev. 2017 Nov 21;11(11):CD011144. doi: 10.1002/14651858.CD011144.pub2.

引用本文的文献

1
Common and Distinct Neural Mechanisms Underlying Risk Seeking and Risk Aversion: Evidence From the Neuroimaging Meta-Analysis.寻求风险和规避风险背后的共同和不同神经机制:来自神经影像学荟萃分析的证据
Hum Brain Mapp. 2025 Aug 1;46(11):e70295. doi: 10.1002/hbm.70295.
2
Investigating behavioural addictions in adults with and without attention deficit hyperactivity disorder.调查患有和未患有注意力缺陷多动障碍的成年人的行为成瘾情况。
PLoS One. 2025 Feb 5;20(2):e0317525. doi: 10.1371/journal.pone.0317525. eCollection 2025.
3
High vs. Low Intensity Behavior Therapy Delivered to Adolescents with ADHD: Potential Adverse Long-Term Effects on Substance Use Outcomes.
高强度与低强度行为疗法用于多动症青少年:对物质使用结果的潜在长期不良影响
Res Child Adolesc Psychopathol. 2025 May;53(5):701-713. doi: 10.1007/s10802-024-01254-1. Epub 2024 Oct 14.
4
Attention-deficit/hyperactivity disorder combined subtype exacerbates opioid use disorder consequences: Mediation by impulsive phenotypes.注意缺陷多动障碍合并亚型加重阿片类使用障碍后果:冲动表型的中介作用。
Drug Alcohol Depend. 2024 Jun 1;259:111292. doi: 10.1016/j.drugalcdep.2024.111292. Epub 2024 Apr 13.
5
Adolescent Neurodevelopment Within the Context of Impulsivity and Substance Use.冲动性与物质使用背景下的青少年神经发育
Curr Addict Rep. 2023 Jun;10(2):166-177. doi: 10.1007/s40429-023-00485-4. Epub 2023 May 2.
6
Challenges of Treating ADHD with Comorbid Substance Use Disorder: Considerations for the Clinician.治疗合并物质使用障碍的注意力缺陷多动障碍的挑战:临床医生需考虑的因素
J Clin Med. 2023 Apr 24;12(9):3096. doi: 10.3390/jcm12093096.
7
Distinct brain structural abnormalities in attention-deficit/hyperactivity disorder and substance use disorders: A comparative meta-analysis.注意力缺陷多动障碍和物质使用障碍的大脑结构异常:一项比较性荟萃分析。
Transl Psychiatry. 2022 Sep 6;12(1):368. doi: 10.1038/s41398-022-02130-6.
8
Attention-Deficit Hyperactivity Disorder and Therapeutic Cannabis Use Motives.注意缺陷多动障碍与治疗性大麻使用动机
Psychiatr Clin North Am. 2022 Sep;45(3):503-514. doi: 10.1016/j.psc.2022.05.010. Epub 2022 Aug 1.
9
Co-occurring Mental Disorders in Transitional Aged Youth With Substance Use Disorders - A Narrative Review.患有物质使用障碍的过渡年龄青年中的共病精神障碍——一项叙述性综述
Front Psychiatry. 2022 Feb 24;13:827658. doi: 10.3389/fpsyt.2022.827658. eCollection 2022.
10
Effects of family history of substance use disorder on reward processing in adolescents with and without attention-deficit/hyperactivity disorder.物质使用障碍家族史对注意缺陷多动障碍和非注意缺陷多动障碍青少年奖赏加工的影响。
Addict Biol. 2022 Mar;27(2):e13137. doi: 10.1111/adb.13137.